Sentinel node tumor burden according to the rotterdam criteria is the most important prognostic factor for survival in melanoma patients: A multicenter study in 388 ratients with positive sentinel nodes

C. J. Alexander, Zbigniew I. Nowecki, Christiane Voit, Gregor Schäfer-Hesterberg, Wanda Michej, Johannes H.W. De Wilt, Piotr Rutkowski, Cornelis Verhoef, Alexander M.M. Eggermont

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

224 Citaten (Scopus)

Samenvatting

Summary Background Data: The more intensive sentinel node (SN) pathologic workup, the higher the SN-positivity rate. This is characterized by an increased detection of cases with minimal tumor burden (SUB-micrometastasis <0.1 mm), which represents different biology. Methods: The slides of positive SN from 3 major centers within the European Organization of Research and Treatment of Cancer (EORTC) Melanoma Group were reviewed and classified according to the Rotterdam Classification of SN Tumor Burden (<0.1 mm; 0.1-1 mm; >1 mm) maximum diameter of the largest metastasis. The predictive value for additional nodal metastases in the comple- tion lymph node dissection (CLND) and disease outcome as disease- free survival (DFS) and overall survival (OS) was calculated. Results: In 388 SN positive patients, with primary melanoma, median Breslow thickness was 4.00 mm; ulceration was present in 56%. Forty patients (10%) had metastases <0.1 mm. Additional nodal positivity was found in only 1 of 40 patients (3%). At a mean follow-up of 41 months, estimated OS at 5 years was 91% for metastasis <0.1 mm, 61% for 0.1 to 1.0 mm, and 51% for >1.0 mm (P < 0.001). SN tumor burden increased significantly with tumor thickness. When the cut-off value for SUB-micrometastases was taken at <0.2 mm (such as in breast cancer), the survival was 89%, and 10% had additional non-SN nodal positivity. Conclusion: This large multicenter dataset establishes that patients with SUB-micrometastases <0.1 mm have the same prognosis as SN negative patients and can be spared a CLND. A <0.2 mm cut-off for SUB-micrometastases does not seem correct for melanoma, as 10% additional nodal positivity is found.

Originele taal-2Engels
Pagina's (van-tot)949-954
Aantal pagina's6
TijdschriftAnnals of Surgery
Volume248
Nummer van het tijdschrift6
DOI's
StatusGepubliceerd - dec. 2008
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Sentinel node tumor burden according to the rotterdam criteria is the most important prognostic factor for survival in melanoma patients: A multicenter study in 388 ratients with positive sentinel nodes'. Samen vormen ze een unieke vingerafdruk.

Citeer dit